NYSE: FUL · Industrial Applications and Services · 17 alerts · CIK 39368
Share price
$49.00Close, Nov 16
Market cap
$2.64B
Shares outstanding
53.83MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Adhesives & SealantsSIC 2891
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Fuller H B Co filings on SEC EDGAR ↗
Robert J. Martsching resigned as Vice President, Corporate Controller, and principal accounting officer effective November 9, 2026. The Board appointed Sarah R. Nickless, previously the Director of Financial Planning & Analysis, to succeed him in these roles. Mr. Martsching will remain with the company through January 2027 to assist with the financial integration of the pending acquisition of Advanced Medical Solutions Group plc.
Fuller H B Exec VP, Business Transform. Nathan D. Weaver Sells $60.5K of Stock
Nathan D. Weaver, Exec VP, Business Transform., sold 1,200 shares of Fuller H B Co at $50.42 a share, worth $60.5K in total on Nov 11, 2026. Shares held after the trade: 10,736 (-10.1%).
Fuller H B $850M Debt Financing with U.S. Bank Trust Company, National Association
H.B. Fuller Company completed the private sale of $850 million in 7.625% senior unsecured notes due 2034. A portion of the proceeds ($450 million) is subject to a special mandatory redemption if the company's pending acquisition of Advanced Medical Solutions Group plc is not consummated by June 25, 2027.
Fuller H B Senior VP, BAS Muhammad Shahbaz Malik Buys $25K of Stock
Muhammad Shahbaz Malik, Senior VP, BAS, bought 479 shares of Fuller H B Co at $52.23 a share, worth $25K in total on Oct 16, 2026. Shares held after the trade: 14,176 (+3.5%).
Fuller H B Signs $1.4B M&A Deal with Ancora Holdings Group LLC
H.B. Fuller's Board of Directors unanimously rejected a second unsolicited, non-binding proposal from Ancora Holdings Group LLC to acquire the Company's Building Adhesive Solutions (BAS) business for $1.2 billion to $1.4 billion. The Board determined the offer undervalued the segment and lacked sufficient detail, though the Company will conduct a market check for select market segments and product lines by year-end 2026 to evaluate potential divestitures for deleveraging.